Duey Marc
- SEC CIK
- 0001925150
In the past year, 1 open-market purchase filing worth $25.1K and no sales.
Current role at each company
- APRE Aprea Therapeutics, Inc.Directoras of Jun 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $25.1K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$25.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Duey Marc as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 (view filing) | Dec 10 | 1 day | Duey MarcDirector | PPurchase | +21.5K | $1.17 | +$25.1K | +9.1%256.2K after | |
| Dec 11, 2025 (view filing) | Dec 10 | 1 day | Duey MarcDirector | PPurchase | +21.5K | – | – | –21.5K after | Derivative |
| Oct 25, 2024 (view filing) | Oct 18 | 7 daysLate | Duey MarcDirector | SSale | −6.46K | $4.58 | −$29.6K | −2.7%233.7K after | |
| Oct 17, 2024 (view filing) | Oct 16 | 1 day | Duey MarcDirector | PPurchase | +30.0K | $4.39 | +$131.7K | +14.3%240.1K after | |
| Oct 16, 2024 (view filing) | Oct 14 | 2 days | Duey MarcDirector | PPurchase | +190 | $2.58 | +$490.2 | +0.1%210.1K after |